# RareCyte

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rarecyte

- Industry: Biotechnology
- Headquarters: Seattle, US
- Website: www.rarecyte.com
- Total disclosed funding: $46M
- Latest round: Series G (Aug 19, 2021)
- Investors on record: 6

## About

Based in the US, RareCyte, Inc. develops innovative tools and solutions for spatial biology and liquid biopsy, enhancing research capabilities and advancing precision medicine.Founded in 2009, RareCyte, Inc. is headquartered in Seattle, US, and specializes in spatial biology and liquid biopsy technologies. The firm has completed five funding deals, with the most recent occurring on June 27, 2024, when RareCyte raised USD 20.00 mn in a venture funding round co-led by Arboretum Ventures and F-Prime Capital. The company was established by experienced entrepreneurs in the biotech field, well-versed in driving innovation within the life sciences sector.RareCyte offers products that include the Orion Spatial Imager and CyteFinder, both designed to facilitate high-performance imaging and rare cell analysis. These tools enable researchers to conduct precise analyses in areas such as circulating tumor cell research and other clinical studies, addressing challenges in tissue discovery and non-invasive diagnostics.The company's revenue is primarily generated through the sale of its imaging instruments and assay development services. Direct sales to research institutions and biotechnology companies include equipment purchases and associated services for clinical trials. Contracts often feature milestone-based payments for bespoke assay development, catering to specific research needs and timelines.In June 2024, RareCyte, Inc. secured USD 20.00 mn in venture funding to support expansion of its Orion Spatial Biology platform. Future growth plans include the launch of new products aimed at enhancing spatial biology solutions and an expansion into key markets across North America, Europe, and Asia within the next year.

## Funding rounds

- Series G, Aug 19, 2021, $24M — 5AM Ventures, Agilent Technologies, Arboretum Ventures, F-Prime Capital, HealthQuest Capital, Logos Capital
- Series F, Dec 19, 2019, $22M — 5AM Ventures, HealthQuest Capital

## Investors

- 5AM Ventures (https://capitalatlas.ai/funds/5am-ventures) — Series F, Series G
- HealthQuest Capital (https://capitalatlas.ai/funds/healthquest-capital) — Series F, Series G
- Agilent Technologies — Series G
- Arboretum Ventures (https://capitalatlas.ai/funds/arboretum-ventures) — Series G
- F-Prime Capital (https://capitalatlas.ai/funds/f-prime-capital) — Series G
- Logos Capital (https://capitalatlas.ai/funds/logos-capital) — Series G